Anti-VEGFA antibody [EP1176Y] - C-terminal
- RabMAb
- Recombinant
- Lab Essentials
- 20ul selling size
- What is this?
5
(9 Reviews)
|
(299 Publications)
Anti-VEGFA antibody [EP1176Y] - C-terminal (ab52917) is a rabbit monoclonal antibody detecting VEGFA in Flow Cytometry (Intra), Flow Cytometry, IHC-P, ICC/IF. Suitable for Human, Mouse.
- Biophysical QC for unrivalled batch-batch consistency
- Over 220 publications
- Trusted since 2007
View Alternative Names
VEGF, VEGFA, L-VEGF, Vascular permeability factor, VPF
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-VEGFA antibody [EP1176Y] - C-terminal (AB52917)
Immunohistochemical analysis of formalin fixed paraffin embedded human kidney labelling VEGFA with ab52917 at a concentration of 2µg/ml. The immunostaining was performed on a Ventana DISCOVERY ULTRA (Roche Tissue Diagnostics) instrument with a ChromoMap DAB IHC Detection Kit followed by anti rabbit HQ and anti HQ HRP detection. Heat mediated antigen retrieval was performed with DISCOVERY cell conditioning solution (CC1) 100°C, pH8.5 for 64mins.
ab52917 Anti-VEGFA antibody [EP1176Y] was incubated for 16mins at 37°C. Sections were counterstained with Hematoxylin II. Image inset shows absence of staining in secondary antibody only control.
Customers are encouraged to optimise antigen retrieval conditions, antibody concentration, incubation times and temperature for best results in their own IHC assay workflow (automated and manual).
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-VEGFA antibody [EP1176Y] - C-terminal (AB52917)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human kidney tissue sections labeling VEGFA with purified ab52917 at 1 : 100 dilution (2.96 μg/ml).
Heat mediated antigen retrieval was performed using citrate buffer, pH 6.0.
Negative control shown in inset.
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-VEGFA antibody [EP1176Y] - C-terminal (AB52917)
Intracellular Flow Cytometry analysis of NIH/3T3 (Mouse embryonic fibroblast) cells labeling VEGFA with purified ab52917 at 1/30 dilution (10μg/ml) (red).
Cells were fixed with 4% paraformaldehyde. A Goat anti rabbit IgG (Alexa Fluorr® 488) secondary antibody was used at 1/2000 dilution. Isotype control - Rabbit monoclonal IgG (Black).
Unlabeled control - Cell without incubation with primary antibody and secondary antibody (Blue).
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-VEGFA antibody [EP1176Y] - C-terminal (AB52917)
Purified ab52917 staining VEGF in NIH/3T3 (Mouse embryo fibroblast cell line) cells.
The cells were fixed with 4% formaldehyde (10 min), permeabilized with 0.1% Triton X-100 for 5 minutes and then blocked in 1% BSA/10% normal goat serum/0.3M glycine in 0.1%PBS-Tween for 1h. The cells were then incubated with purified ab52917 at 5 μg/ml and ab195884, at 1/250 dilution, overnight at +4°C, followed by a further incubation at room temperature for 1h with an Goat anti-Rabbit Alexa Fluor®488 secondary (ab150081) at 2 μg/ml (shown in green).
Nuclear DNA was labeled in blue with DAPI.
- IHC-P
AbReview38570****
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-VEGFA antibody [EP1176Y] - C-terminal (AB52917)
Unpurified ab52917 staining VEGF in mouse kidney tissue sections by Immunohistochemistry (IHC-P - paraformaldehyde-fixed, paraffin-embedded sections).
Tissue was fixed with paraformaldehyde, permeabilized with 0.3% Triton X-100 and blocked with 5% serum for 45 minutes at 25°C. Samples were incubated with primary antibody (1/400 in 4% BSA + 5% serum in PBST) for 14 hours at 4°C. An Alexa Fluor® 546-conjugated Donkey anti-rabbit IgG polyclonal (1/300) was used as the secondary antibody.
This image is courtesy of an anonymous Abreview.
Related conjugates and formulations (6)
-
578 PE
PE Anti-VEGFA antibody [EP1176Y]
-
Biotin Anti-VEGFA antibody [EP1176Y]
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-VEGFA antibody [EP1176Y]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-VEGFA antibody [EP1176Y]
-
Anti-VEGFA antibody [EP1176Y] - BSA and Azide free
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-VEGFA antibody [EP1176Y]
Reactivity data
Product details
Abcam recommended secondaries - Goat Anti-Rabbit HRP (ab205718) and Goat Anti-Rabbit Alexa Fluor® 488 (ab150077). Or search our wide range of secondary antibodies for use with your experiment.
Product Specifications
Anti-VEGFA antibody [EP1176Y] - C-terminal (ab52917) was developed by Abcam using patented rabbit monoclonal antibody technology and is validated for use in Flow Cyt (Intra), ICC/IF, IHC-P in human, mouse samples.
Anti-VEGFA antibody [EP1176Y] - C-terminal (ab52917) specifically detects VEGFA (UniProt ID: P15692; Molecular weight: 44kDa) and is sold in a convenient trial size to enable initial testing (20 µL) and larger sizes for subsequent scaling up experiments (100 µL and 1 mL).
Quality and Validation
Abcam's high quality manufacturing and validation processes ensure Anti-VEGFA antibody [EP1176Y] - C-terminal (ab52917) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility.
Anti-VEGFA antibody [EP1176Y] - C-terminal (ab52917) has been cited over 221 times in peer reviewed journals and is trusted by the scientific community.
Anti-VEGFA antibody [EP1176Y] - C-terminal (ab52917) has 9 independent reviews from customers.
Related Products
Conjugation-ready, carrier free format available for antibody clone EP1176Y - ab212816.
Antibody clone EP1176Y is also available pre-conjugated to a variety of labels for your convenience - Biotin, Alexa Fluor® 488, Alexa Fluor® 647, Alexa Fluor® 594, PE (ab195902, ab206886, ab206887, ab206888, ab209439).
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
VEGFA functions by promoting the proliferation and migration of vascular endothelial cells. It operates both as a homodimer and as part of complex signaling cascades interacting with VEGF receptors on cell surfaces to trigger downstream signals for angiogenesis. This includes endothelial cell growth migration and the new blood vessel formation process. VEGFA's activity is important for physiological processes such as wound healing and embryonic development and it also contributes to pathological conditions through its unregulated expression in diseases.
Pathways
Many processes involve VEGFA including the PI3K/AKT pathway and the MAPK/ERK pathway. These pathways regulate cell survival growth and differentiation. Other proteins like PLGF (placenta growth factor) and VEGFB often accompany VEGFA in these pathways aiding in distinct but overlapping roles. These interactions are transmitted through binding to VEGF receptors such as VEGFR-1 and VEGFR-2 subsequently activating various signaling cascades necessary for cellular and tissue homeostasis.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (299)
Recent publications for all applications. Explore the full list and refine your search
Journal of translational medicine 23:1056 PubMed41053808
2025
Applications
Unspecified application
Species
Unspecified reactive species
Signal transduction and targeted therapy 10:287 PubMed40908300
2025
Applications
Unspecified application
Species
Unspecified reactive species
Neoplasia (New York, N.Y.) 68:101219 PubMed40840329
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cells 14: PubMed40710334
2025
Applications
Unspecified application
Species
Unspecified reactive species
Drug design, development and therapy 19:6183-6205 PubMed40698062
2025
Applications
Unspecified application
Species
Unspecified reactive species
American journal of translational research 17:4387-4398 PubMed40672635
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 16:5392 PubMed40562785
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of scleroderma and related disorders :23971983251344040 PubMed40476199
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cell communication and signaling : CCS 23:108 PubMed40001144
2025
Applications
Unspecified application
Species
Unspecified reactive species
ACS biomaterials science & engineering 11:2226-2235 PubMed39970159
2025
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com